المؤلفون: Mambule I; Department of Research, Joint Clinical Research Centre, Kampala, Uganda. Electronic address: imambule@jcrc.org.ug., Norcross C; MRC/UVRI-LSHTM Uganda Research Unit, Entebbe, Uganda., Achieng Ombajo L; Department of Clinical Medicine and Therapeutics, University of Nairobi, Nairobi, Kenya; Center for Epidemiological Modelling and Analysis, University of Nairobi, Nairobi, Kenya., Sokhela S; Ezintsha, Johannesburg, South Africa., Laker Odongpiny EA; Department of Prevention, Care and Treatment, Infectious Diseases Institute, Kampala, Uganda; School of Medicine, University of St Andrews, St Andrews, UK., Owarwo N; Department of Prevention, Care and Treatment, Infectious Diseases Institute, Kampala, Uganda., Lawrence DS; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK; Botswana Harvard Health Partnership, Northring Road, Gaborone, Botswana., Ruzagira E; MRC/UVRI-LSHTM Uganda Research Unit, Entebbe, Uganda; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK., Cresswell FV; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK; MRC/UVRI-LSHTM Uganda Research Unit, Entebbe, Uganda; Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, UK.

المصدر: The lancet. HIV [Lancet HIV] 2024 Jun; Vol. 11 (6), pp. e419-e426. Date of Electronic Publication: 2024 Apr 30.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*/drug therapy , Pyridones*/administration & dosage , Pyridones*/therapeutic use , Oxazines*/therapeutic use , Oxazines*/administration & dosage , Heterocyclic Compounds, 3-Ring*/therapeutic use , Heterocyclic Compounds, 3-Ring*/administration & dosage , Anti-HIV Agents*/therapeutic use , Anti-HIV Agents*/administration & dosage , Lamivudine*/therapeutic use , Lamivudine*/administration & dosage , Piperazines*/administration & dosage , Piperazines*/therapeutic use, Humans ; Africa/epidemiology ; Female ; Rilpivirine/therapeutic use ; Rilpivirine/administration & dosage ; Drug Therapy, Combination ; Male ; Adolescent ; Adult ; Diketopiperazines